PROPHYLAXIS OF BLEEDING
Clinical trials for PROPHYLAXIS OF BLEEDING explained in plain language.
Never miss a new study
Get alerted when new PROPHYLAXIS OF BLEEDING trials appear
Sign up with your email to follow new studies for PROPHYLAXIS OF BLEEDING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with severe bleeding disorder: Extended-Release treatment tested
Disease control CompletedThis study tested the safety of a longer-lasting clotting factor injection called BAY94-9027 (Jivi) in children aged 7 to under 12 with severe hemophilia A. The treatment is designed to prevent and control bleeding episodes with fewer injections than standard therapies. Researche…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New score aims to tailor bleeding disorder treatment, reduce injections
Disease control CompletedThis study tested a new scoring system to help doctors personalize treatment plans for people with hemophilia A when switching to a longer-lasting medication called Jivi. The score used factors like a person's bleeding history and activity level to assign one of three dosing sche…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC